Followers | 145 |
Posts | 27568 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Tuesday, May 11, 2021 7:55:15 AM
https://finance.yahoo.com/news/rewalk-robotics-reports-first-quarter-112300986.html
— First Quarter 2021 Total Revenue of $1.3 million —
— Strong balance sheet with $ 67.4 million in cash, as of March 31, 2021—
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 11, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three months ended March 31, 2021.
Highlights of and subsequent to the first quarter of 2021 include:
The Company’s total revenue in the first quarter of 2021 was $1.3 million, compared to $0.8 million in the prior year’s first quarter;
The Company’s gross margin was 54% in Q1 of 2021, compared to 49% in Q1 of 2020;
The Company’s operating expenses were $3.7 million in Q1 of 2021, compared to $4 million in Q1 2020;
The Company entered into a contract with BKK Mobile Oil health insurance to supply ReWalk’s Personal 6.0 System to eligible persons in Germany; and
The Company has a strong balance sheet with $67.4 million in cash as of March 31, 2021.
“We are encouraged by the results shown in the first quarter of 2021,” said Larry Jasinski, ReWalk’s Chief Executive Officer. “We see areas of our direct markets gradually reopening, which allows us to increase trials of ReWalk’s new Personal 6.0 System with patients and return to in-clinic demonstrations of our rehab products for new potential users. As we look forward into 2021, we remain focused on progressing our CMS coverage and broadening our German market access. We believe we remain on track to achieve our 2021 objectives and we have a strong cash position that allows us to explore further opportunities for growth.”
First Quarter 2021 Financial Results
Total revenue was $1.3 million the first quarter of 2021, compared to $0.8 million during first quarter of the prior year. The increase is due to additional ReWalk Personal 6.0 units sold in Germany and the United States.
Gross margin was 54% during the first quarter of 2021, compared to 49% in the first quarter of 2020. The increase is due primarily to the higher number of units sold during the quarter as compared to the same period in the previous year.
Total operating expenses in the first quarter of 2021 were $3.7 million, compared to $4 million in the first quarter of the prior year.
Net loss was $3.1 million for the first quarter of 2021, compared to a net loss of $3.8 million in the first quarter of the prior year.
Non-GAAP net loss was $2.8 million in the first quarter of 2021, compared to $3.6 million during the first quarter of the prior year. Reconciliation of net loss to non-GAAP net loss is included at the end of this press release.
Liquidity
As of March 31, 2021, ReWalk had $67.4 million in cash on its balance sheet.
Conference Call
ReWalk management will host its first quarter 2021 conference call as follows:
Date
Tuesday, May 11, 2021
Time
8:30 AM EDT
Telephone
U.S:
(844) 423-9889
International:
(716) 247-5804
Israel:
18 09 31 53 62
Germany:
08 00 18 15 287
Access code
5966026
Webcast (live, listen-only and archive)
www.rewalk.com under the “Investors” section.
The archived webcast will be available via the following URL
https://edge.media-server.com/mmc/p/dkwioh4r or through the 'Investors' section' on www.rewalk.com.
Recent RWLK News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 01:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:15:21 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/29/2024 12:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:16:29 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/19/2024 12:46:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/04/2024 01:01:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2024 11:34:09 AM
- VA STAND Act introduced in the United States Senate • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- Lifeward Announces Reverse Share Split • GlobeNewswire Inc. • 03/13/2024 03:45:17 PM
- ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy • GlobeNewswire Inc. • 03/08/2024 01:30:00 PM
- Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may b • GlobeNewswire Inc. • 03/01/2024 01:45:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 02:15:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:15:25 PM
- Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 01:00:07 PM
- Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/20/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:15:24 PM
- ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward • GlobeNewswire Inc. • 01/29/2024 01:00:00 PM
- ReWalk Robotics Expands Direct Sales Coverage to Canada • GlobeNewswire Inc. • 01/12/2024 01:30:00 PM
- ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17 • GlobeNewswire Inc. • 01/11/2024 10:00:06 PM
- First ReWalk Personal Exoskeleton Claim Paid by Medicare • GlobeNewswire Inc. • 01/05/2024 01:00:00 PM
- ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:04:05 PM
- ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting • GlobeNewswire Inc. • 11/30/2023 09:45:00 PM
- ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype • GlobeNewswire Inc. • 11/28/2023 01:00:00 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM